Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -15.57% is 63% above its 5-year average of -41.87%, near the high end of its 5-year range (-152.48%–-9.36%).
As of the fiscal period ended Wednesday, December 31, 2025. 24.91% above its 12-month average of -20.73%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -36.62%.
RETURN ON ASSETS (ROA)
-15.57%
RETURN ON ASSETS (ROA) AVG TTM
-20.73%
RETURN ON ASSETS (ROA) AVG 3Y
-20.84%
RETURN ON ASSETS (ROA) AVG 5Y
-41.87%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+24.91%
CURRENT VS 3Y AVG
+25.31%
CURRENT VS 5Y AVG
+62.81%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.27%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+51.74%
vs the sector median at left
Pulsenmore Ltd. Ordinary Shares
Market Cap
$14.05M
Return on Assets (ROA)
-15.57%
TTM Avg
-20.73%
3Y Avg
-20.84%
5Y Avg
-41.87%
Market Cap
$13.86M
Return on Assets (ROA)
-172.58%
TTM Avg
-148.41%
3Y Avg
-106.72%
5Y Avg
-82.10%
Market Cap
$13.75M
Return on Assets (ROA)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.46M
Return on Assets (ROA)
-123.23%
TTM Avg
-153.35%
3Y Avg
-205.77%
5Y Avg
-166.29%
Market Cap
$14.73M
Return on Assets (ROA)
-201.89%
TTM Avg
-113.65%
3Y Avg
-83.24%
5Y Avg
-72.72%
Market Cap
$13.33M
Return on Assets (ROA)
-85.85%
TTM Avg
-102.78%
3Y Avg
-95.22%
5Y Avg
-76.09%
Market Cap
$13.30M
Return on Assets (ROA)
-27.12%
TTM Avg
-32.94%
3Y Avg
-35.27%
5Y Avg
-29.16%
Market Cap
$13.20M
Return on Assets (ROA)
-32.53%
TTM Avg
-31.07%
3Y Avg
-30.77%
5Y Avg
-29.89%
Market Cap
$14.94M
Return on Assets (ROA)
-41.18%
TTM Avg
-60.23%
3Y Avg
-53.11%
5Y Avg
-40.22%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulsenmore Ltd. Ordinary Shares (PLSM) | $14.05M | -15.57% | -20.73% | -20.84% | -41.87% |
| Sintx Technologies, Inc. (SINT)vs › | $13.86M | -172.58% | -148.41% | -106.72% | -82.10% |
| Obsidian Therapeutics Inc. (OBX)vs › | $13.75M | N/A | N/A | N/A | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $14.46M | -123.23% | -153.35% | -205.77% | -166.29% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.73M | -201.89% | -113.65% | -83.24% | -72.72% |
| IN8bio, Inc. (INAB)vs › | $13.33M | -85.85% | -102.78% | -95.22% | -76.09% |
| Optimi Health Corp. (OPTH)vs › | $13.30M | -27.12% | -32.94% | -35.27% | -29.16% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.20M | -32.53% | -31.07% | -30.77% | -29.89% |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.94M | -41.18% | -60.23% | -53.11% | -40.22% |
| Passage Bio, Inc. (PASG)vs › | $13.11M | -143.44% | -68.17% | -65.00% | -57.74% |
ROA
-15.6%
ROE
-19.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -15.57% |
| 2024-12-31 | -25.90% |
| 2023-12-31 | -32.55% |
| 2022-12-31 | -9.36% |
| 2021-12-31 | -15.33% |
| 2020-12-31 | -152.48% |
| 2019-12-31 | -73.34% |
